Atorwon 10 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Wonkwang Pharmaceutical Co., Ltd.
MFDS item code 202000816 · Approved 2020.02.11
This product's status changed to Expired on 2025.02.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hyperlipidemia (including in children) and prevention of cardiovascular events (such as myocardial infarction and stroke)
This medication helps to reduce the risk of cardiovascular diseases. For instance, it lowers the risk of myocardial infarction and stroke in adults with multiple risk factors for coronary heart disease or patients with type 2 diabetes. It also reduces risks associated with vascular reconstruction, chronic stable angina, and hospitalization for congestive heart failure. Additionally, in patients with hyperlipidemia, it helps manage blood lipids by lowering total cholesterol, LDL cholesterol, and triglyceride levels, while increasing HDL cholesterol when used alongside dietary adjustments. Particularly, it is used to regulate cholesterol levels in pediatric patients with heterozygous familial hypercholesterolemia. Therefore, this medication is used for reducing the risk of cardiovascular diseases and treating hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin, and may take it at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking into account treatment goals and response. Lipid levels should be analyzed 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients aged 70 years and older are generally similar to those in adult patients.
10 ~ 17 years: The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses higher than 20 mg of this drug in pediatric patients).
This medication may cause abnormal symptoms in muscles, thus if symptoms such as muscle pain or weakness worsen or if creatine kinase levels drastically increase, usage should be immediately discontinued. Particularly, it may be necessary to temporarily pause treatment in cases of acute infection, hypotension, major surgeries or trauma, severe metabolic disorders, or liver diseases. Those with allergies to this medication or its components, acute liver disease, muscle diseases, women who are pregnant or nursing, and children under 10 years should not take this medication. Individuals with a history of alcoholism, liver disease, poor kidney function, hypothyroidism, hereditary muscle diseases, and elderly patients should consult a doctor before taking this medication and use it with caution. This medication may affect liver function, so regular liver function tests should be conducted, and any abnormal symptoms should be reported immediately. Women of childbearing age should use appropriate contraception while taking this medication and should discontinue if pregnancy is confirmed. This medication can interact with several other drugs, so anyone taking other medications must inform their doctor or pharmacist. There is no specific antidote for overdose; treatment should be based on symptoms, and regular liver and muscle-related tests should be carried out. Store this medication out of the reach of children, and keep it in its original container to maintain quality. During the use of this medication, it is important to inform a doctor immediately if symptoms such as muscle pain, fatigue, or fever develop.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to protect it from air and moisture. The suitable storage temperature is between 1 and 30 degrees Celsius at room temperature, and it is advisable to avoid extremes of heat and cold.
White round film-coated tablet
Bottle packaging - 30 tablets/bottle, bottle packaging - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Atorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Wonkwang Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.